VFA
LJPC

Valeo Financial Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Valeo Financial Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-500
Closed -$2K – 2008
2019
Q4 		$2K Hold
500
– – ﹤0.01% 1509
2019
Q3 		$4K Buy
+500
New +$4.72K ﹤0.01% 1294

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Valeo Financial Advisors's LJPC Position: Q1 2020 in Review

Valeo Financial Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2020, closing a stake of 500 shares — an estimated $2K sold.

Valeo Financial Advisors first reported a position in LJPC in Q3 2019 and held it in 2 quarters. The position peaked at $4K in Q3 2019. 73 funds tracked by Wall St. Rank hold LJPC as of Q1 2020.

  • Valeo Financial Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q1 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 500 La Jolla Pharmaceutical Company shares in Q1 2020, an estimated $2K.
  • Valeo Financial Advisors first reported a position in La Jolla Pharmaceutical Company in Q3 2019 and held it in 2 quarters.
  • Valeo Financial Advisors's La Jolla Pharmaceutical Company position peaked at $4K in Q3 2019.
  • 73 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2020.

Based on Valeo Financial Advisors's 13F filing for Q1 2020, filed 13 Apr 2020.